ATLANTA, GA -- (Marketwire) -- 08/18/09 -- Holzer Holzer & Fistel, LLC announces that a
class action lawsuit has been filed in the United States District Court for
the Eastern District of Michigan on behalf of purchasers of Caraco
Pharmaceutical Laboratories, Ltd. ("Caraco" or the "Company") (AMEX: CPD)
who purchased shares between May 29, 2008 and June 25, 2009, inclusive (the
"Class Period"). The lawsuit alleges the Company failed to disclose
problems it was having complying with certain FDA regulations. Further, the
complaint alleges that Caraco misrepresented or failed to disclose material
information relating to its efforts to obtain FDA approval for certain of
its drugs.
If you purchased shares of Caraco common stock during the Class Period, you
have the legal right to petition the Court to be appointed a "lead
plaintiff." A lead plaintiff is a representative party that acts on behalf
of other class members in directing the litigation. Any such request must
satisfy certain criteria and be made no later than September 15, 2009. Any
member of the purported class may move the Court to serve as lead plaintiff
through counsel of their choice, or may choose to do nothing and remain an
absent class member. If you are a Caraco investor and would like to discuss
a potential lead plaintiff appointment, or your rights and interests with
respect to the lawsuit, you may contact Michael I. Fistel, Jr., Esq., or
Marshall P. Dees, Esq. via email at mfistel@holzerlaw.com, or
mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832.
Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates
its practice to vigorous representation of shareholders and investors in
litigation nationwide, including shareholder class action and derivative
litigation. More information about the firm is available through its
website, www.holzerlaw.com and upon request from the firm. Holzer Holzer &
Fistel, LLC has paid for the dissemination of this promotional
communication, and Michael I. Fistel, Jr. is the attorney responsible for
its content.
